These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29635462)

  • 1. Low prevalence of transmitted HIV-1 drug resistance detected by a dried blood spot (DBS)-based next-generation sequencing (NGS) method in newly diagnosed individuals in Cameroon in the years 2015-16.
    Mbunkah HA; Marzel A; Schmutz S; Kok YL; Zagordi O; Shilaih M; Nsanwe NN; Mbu ET; Besong LM; Sama BA; Orock E; Kouyos RD; Günthard HF; Metzner KJ
    J Antimicrob Chemother; 2018 Jul; 73(7):1917-1929. PubMed ID: 29635462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey.
    Sayan M; Sargin F; Inan D; Sevgi DY; Celikbas AK; Yasar K; Kaptan F; Kutlu S; Fisgin NT; Inci A; Ceran N; Karaoglan I; Cagatay A; Celen MK; Koruk ST; Ceylan B; Yildirmak T; Akalın H; Korten V; Willke A
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):26-31. PubMed ID: 26414663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort.
    Sarinoglu RC; Sili U; Hasdemir U; Aksu B; Soyletir G; Korten V
    Curr HIV Res; 2022; 20(1):54-62. PubMed ID: 34802406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort.
    Machnowska P; Meixenberger K; Schmidt D; Jessen H; Hillenbrand H; Gunsenheimer-Bartmeyer B; Hamouda O; Kücherer C; Bannert N;
    PLoS One; 2019; 14(1):e0209605. PubMed ID: 30650082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
    Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
    J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validated in-house assay for HIV drug resistance mutation surveillance from dried blood spot specimens.
    Neufeld B; Munyuza C; Reimer A; Capiña R; Lee ER; Becker M; Sandstrom P; Ji H; Cholette F
    J Virol Methods; 2024 Jun; 327():114939. PubMed ID: 38604585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom.
    Tostevin A; White E; Dunn D; Croxford S; Delpech V; Williams I; Asboe D; Pozniak A; Churchill D; Geretti AM; Pillay D; Sabin C; Leigh-Brown A; Smit E;
    HIV Med; 2017 Mar; 18(3):204-213. PubMed ID: 27476929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity.
    Alexiev I; Shankar A; Wensing AM; Beshkov D; Elenkov I; Stoycheva M; Nikolova D; Nikolova M; Switzer WM
    J Antimicrob Chemother; 2015; 70(6):1874-80. PubMed ID: 25652746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.
    Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L;
    PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
    Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
    J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
    Aghokeng AF; Kouanfack C; Laurent C; Ebong E; Atem-Tambe A; Butel C; Montavon C; Mpoudi-Ngole E; Delaporte E; Peeters M
    AIDS; 2011 Nov; 25(17):2183-8. PubMed ID: 21860346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic.
    Charpentier C; Gody JC; Tisserand P; Matta M; Péré H; Fournier J; Mbitikon O; Bélec L
    Antivir Ther; 2011; 16(8):1347-50. PubMed ID: 22155917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
    Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
    Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of an
    Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines.
    Fokam J; Takou D; Santoro MM; Akonie HZ; Kouanfack C; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):329-33. PubMed ID: 26602836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
    Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
    Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
    Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco.
    Cavalcanti AM; Brito AM; Salustiano DM; Lima KO; Silva SP; Diaz RS; Lacerda HR
    Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):450-7. PubMed ID: 22666853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
    Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
    Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.